Products for Research Use Only

Simtuzumab

CAT: 0931-T76700-02Size: 5 mgDry Ice: NoHazardous: No
Product image 1
1 / 1
CAT#:0931-T76700-02Size:5 mg
Selected
24/48H Stock Items & 2 to 6 Weeks non Stock Items.
Quick Request Actions
CAS Number
1318075-13-6
Target
Monoamine Oxidase
Related Pathways
Neuroscience
Purity
>95%
Bioactivity
Simtuzumab is a monoclonal antibody against lysyl oxidase-like protein 2 (LOXL2) . Simtuzumab can be used to treat primary sclerosing cholangitis (PSC) and is not effective in patients with bridging fibrosis or compensatory cirrhosis caused by non-alcoholic steatohepatitis.
Shipping Conditions
Ice Packs
Storage Temperature
-20°C

Chemical Information

Simtuzumab

Simtuzumab has been used in trials studying the treatment and basic science of Myelofibrosis, Pancreatic Cancer, Colorectal Cancer, and Idiopathic Pulmonary Fibrosis.

CAS Number1318075-13-6
PubChem CID17750227
IUPAC Name4-borono-3-chlorobenzoic acid
Molecular FormulaC7H6BClO4
Molecular Weight200.38
Topological Polar Surface Area77.8
Hydrogen Bond Donor Count3
Hydrogen Bond Acceptor Count4
Rotatable Bond Count2
Heavy Atom Count13
Formal Charge0
Complexity199
SMILES
B(C1=C(C=C(C=C1)C(=O)O)Cl)(O)O
InChI
InChI=1S/C7H6BClO4/c9-6-3-4(7(10)11)1-2-5(6)8(12)13/h1-3,12-13H,(H,10,11)
InChIKey
FYDHSNLXZRGWFU-UHFFFAOYSA-N
Chemical Structure
2D Structure
2D structure of Simtuzumab
CAS: 1318075-13-6
CID: 17750227
Formula: C7H6BClO4
MW: 200.38
Interactive 3D Structure
Loading 3D structure...
Computed Properties
PropertyValue
Molecular Weight200.38
Hydrogen Bond Donor Count3
Hydrogen Bond Acceptor Count4
Rotatable Bond Count2
Exact Mass200.0047665
Monoisotopic Mass200.0047665
Topological Polar Surface Area77.8 Ų
Heavy Atom Count13
Formal Charge0
Complexity199
Isotope Atom Count0
Defined Atom Stereocenter Count0
Undefined Atom Stereocenter Count0
Defined Bond Stereocenter Count0
Undefined Bond Stereocenter Count0
Covalently-Bonded Unit Count1
Compound Is CanonicalizedYes